Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information. (23rd January 2018) - Minetto, Paola; Guolo, Fabio; Clavio, Marino; Kunkl, Annalisa; Colombo, Nicoletta; Carminati, Enrico; Fugazza, Giuseppina; Matarese, Simona; Guardo, Daniela; Ballerini, Filippo; Di Grazia, Carmen; Raiola, Anna M.; et al.